financetom
Business
financetom
/
Business
/
What's Going On With Nano Nuclear Stock Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Nano Nuclear Stock Tuesday?
Oct 7, 2025 10:34 AM

Nano Nuclear Energy Inc. ( NNE ) rose Tuesday after the microreactor developer unveiled plans to open a manufacturing and research hub in Illinois, expanding its U.S. footprint and advancing development of its KRONOS MMR microreactor platform.

The company said it will establish operations in the Chicagoland area in partnership with Governor JB Pritzker and the Illinois Department of Commerce and Economic Opportunity, supported by the state’s REV Illinois program.

Nano Nuclear plans to invest more than $12 million to launch the site and create 50 full-time positions.

Also Read: Why Analysts Are Bearish On Private Equity Stocks After First Brands’ Collapse

The company will receive $6.8 million in REV Illinois incentives tied to capital spending and job creation, reflecting the state’s push to grow advanced manufacturing and clean-energy supply chains.

The firm recently bought a 23,537-square-foot standalone property that includes a 7,400-square-foot non-nuclear demonstration area.

The facility is expected to support engineers, component manufacturers, and researchers developing and validating the KRONOS MMR Microreactor Energy System in collaboration with the University of Illinois Urbana-Champaign.

“With Illinois being the birthplace of the controlled nuclear chain reaction, and the state with the largest nuclear electricity production, it is really exciting to see Nano Nuclear being selected to advance and grow nuclear energy and expertise in the state,” said Dr. Florent Heidet, chief technology officer of Nano Nuclear.

“This new hub will play a central role in our work to construct, demonstrate, and ultimately commercialize our KRONOS MMR Energy System in collaboration with the University of Illinois Urbana-Champaign,” said James Walker, Nano Nuclear’s chief executive officer.

Price Action: NNE shares were trading higher by 7.48% to $57.64 at last check Tuesday.

Read now:

Private Equity Stocks Burn While Wall Street Parties—Is A Credit Crunch Brewing?

Image by Piotr Swat via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MannKind Discontinues Phase 3 Trial of Nebulized Clofazimine to Treat Lung Disease
MannKind Discontinues Phase 3 Trial of Nebulized Clofazimine to Treat Lung Disease
Nov 10, 2025
09:28 AM EST, 11/10/2025 (MT Newswires) -- MannKind ( MNKD ) said Monday it has discontinued its phase 3 trial evaluating MNKD-101, a nebulized clofazimine inhalation suspension, for the treatment of nontuberculous mycobacterial lung disease. The company said no sputum culture conversions were observed from the first 46 participants who completed the double-blind treatment phase and the Data Safety Monitoring...
ADENTRA Q3 Net Income Lowers Despite Rise in Sales; Increases Annual Dividend to C$0.64
ADENTRA Q3 Net Income Lowers Despite Rise in Sales; Increases Annual Dividend to C$0.64
Nov 10, 2025
09:29 AM EST, 11/10/2025 (MT Newswires) -- ADENTRA ( HDIUF ) , one of North America's largest distributors of architectural building products, on Monday reported a fall in net income but still beat forecast for the third quarter on better than expected revenues, while it increased its annual dividend For the three-months ended Sept. 30, the company reported net income...
Sibanye Stillwater Settles Deal Termination Dispute With Appian Capital for $215 Million
Sibanye Stillwater Settles Deal Termination Dispute With Appian Capital for $215 Million
Nov 10, 2025
09:28 AM EST, 11/10/2025 (MT Newswires) -- Sibanye Stillwater ( SBSW ) said Monday that it has agreed to a $215 million commercial settlement with investment firm Appian Capital Advisory over Sibanye's cancellation of a deal to acquire shares of Atlantic Nickel and Mineracao Vale Verde from Appian in January 2022. The two parties have reached an agreement on a...
Novartis opens new plant in California to make cancer drugs
Novartis opens new plant in California to make cancer drugs
Nov 10, 2025
Nov 10 (Reuters) - Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make cancer treatments, as part of its pledge to invest billions into building U.S. sites. The plant will produce radioligand therapies, which are drugs that deliver cell-killing radioactive particles directly to tumors, the company said. Novartis already markets radioligand...
Copyright 2023-2026 - www.financetom.com All Rights Reserved